Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates

被引：12
|
作者：
Di Lullo, Giulia [1 ,2 ]
Marcatti, Magda [3 ]
Protti, Maria Pia [1 ,2 ]
机构：
[1] Ist Sci San Raffaele, IRCCS, Tumor Immunol Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, IRCCS, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, IRCCS, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy
来源：
ONCOIMMUNOLOGY | 2016年 / 5卷 / 04期
关键词：
BM mesenchymal stromal cells; BM microenvironment; bone disease; disease prognosis; IL-13; IL-17; IL-22; multiple myeloma; Th17; cells; Th22; DENDRITIC CELLS; INTERLEUKIN; 22; BONE-DISEASE; IDENTIFICATION; SUBSET; T(H)17; MARROW; IMMUNE; IL-17;
D O I：
10.1080/2162402X.2015.1093278
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We recently reported that in multiple myeloma increased Th22 cell frequencies correlate with poor prognosis. Here we show that within the same patients' cohort Th17 cells associate with bone disease and not with prognosis. Thus, we propose that Th22 and Th17 cells play non-redundant roles in multiple myeloma and constitute independent therapeutic targets.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Th17 and Th22 cells in psoriatic arthritis and psoriasis
    Helen Benham
    Paul Norris
    Jane Goodall
    Mihir D Wechalekar
    Oliver FitzGerald
    Agnes Szentpetery
    Malcolm Smith
    Ranjeny Thomas
    Hill Gaston
    Arthritis Research & Therapy, 15
  • [2] Th17 and Th22 cells in psoriatic arthritis and psoriasis
    Benham, Helen
    Norris, Paul
    Goodall, Jane
    Wechalekar, Mihir D.
    FitzGerald, Oliver
    Szentpetery, Agnes
    Smith, Malcolm
    Thomas, Ranjeny
    Gaston, Hill
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [3] Th17 and Th22 cells in psoriasis and psoriatic arthritis
    Benham, H. J.
    Goodall, J. C.
    Gaston, J. S. H.
    IMMUNOLOGY, 2010, 131 : 57 - 57
  • [4] TH17 AND TH22 CELLS IN PSORIASIS AND PSORIATIC ARTHRITIS
    Benham, H.
    Goodall, J.
    Gaston, H.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 5 - 5
  • [5] Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
    Wang, Min
    Chen, Ping
    Jia, Yan
    He, Na
    Li, Daqi
    Ji, Chunyan
    Ma, Daoxin
    ONCOTARGET, 2015, 6 (20) : 17958 - 17967
  • [6] Th17 and Th22 in Skin Allergy
    Cavani, Andrea
    Pennino, Davide
    Eyerich, Kilian
    NEW TRENDS IN ALLERGY AND ATOPIC ECZEMA, 2012, 96 : 39 - 44
  • [7] Characterisation of Th17, Th22 and regulatory T cells in atopic
    Lewis, B. J.
    Lawson, L. G.
    Hussain, F.
    Kotb, I. S.
    Ormerod, A. D.
    Barker, R. N.
    IMMUNOLOGY, 2011, 135 : 166 - 166
  • [8] Recruitment and significance of Th22 cells and Th17 cells in malignant ascites
    Yang, Xian-Wen
    Jiang, Hai-Xing
    Lei, Ronge
    Lu, Wei-Shun
    Tan, Shi-Hui
    Qin, Shan-Yu
    ONCOLOGY LETTERS, 2018, 16 (04) : 5389 - 5397
  • [9] TH17 BUT NOT TH22 CELLS DISPLAY PATHOLOGICAL BEHAVIOUR IN ARTHRITIS
    van Hamburg, Jan Piet
    Corneth, Odilia B. J.
    Paulissen, Sandra M. J.
    Davelaar, Nadine
    Asmawidjaja, Patrick S.
    Lubberts, Erik
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71
  • [10] Multiparametric analysis of Th17 and Th22 cells discloses their pathogenicity in human multiple sclerosis
    Rolla, Simona
    Bardina, Valentina
    Clerico, Marinella
    Durelli, Luca
    Novelli, Francesco
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 164 - 164
12345